# HCPCS Q5103: Injection, infliximab-dyyb, biosimilar, 10mg

Medicare HCPCS Q5103 has a Medicare Part B payment limit of $28.46 per 10 MG under 2026 Q4 Medicare Part B drug (ASP) pricing, the same in every state.

Web page: https://www.med-reveal.com/rates/Q5103-hcpcs-fee-schedule
Section: Drugs and Biologicals
Billed by: Rheumatology

## Medicare rates

| | Amount |
| --- | --- |
| National non-facility | $28.46 |
| National facility | $28.46 |
| Release | 2026 Q4 (effective 2026-10-01) |

## Related codes

- J1556: Injection, immune globulin, 1g (Bivigam) — https://www.med-reveal.com/rates/J1556-hcpcs-fee-schedule
- J1561: Injection, immune globulin, 500mg (Gamunex/Gammaked) — https://www.med-reveal.com/rates/J1561-hcpcs-fee-schedule
- J1566: Injection, immune globulin, lyophilized, 500mg — https://www.med-reveal.com/rates/J1566-hcpcs-fee-schedule
- P9010: Blood, whole, for transfusion, per unit — https://www.med-reveal.com/rates/P9010-hcpcs-fee-schedule
- P9016: Red blood cells, leukocytes reduced, each unit — https://www.med-reveal.com/rates/P9016-hcpcs-fee-schedule
- P9021: Red blood cells, each unit — https://www.med-reveal.com/rates/P9021-hcpcs-fee-schedule
- P9031: Platelets, leukocytes reduced, each unit — https://www.med-reveal.com/rates/P9031-hcpcs-fee-schedule
- P9040: Platelets, leukoreduced, apheresis/pheresis, each unit — https://www.med-reveal.com/rates/P9040-hcpcs-fee-schedule

Commercial negotiated rates for Q5103 by payer and state: https://www.med-reveal.com/solutions/rate-benchmarking

## Sources

- CMS Medicare fee schedules (2026 Q4): https://www.cms.gov/medicare/payment/fee-schedules